Xiao Hui Ji
Direttore/Membro del Consiglio presso LEGEND BIOTECH CORPORATION
Patrimonio netto: 368 632 $ in data 31/05/2024
Profilo
Xiao Hui Ji is the founder of Elpiscience Biopharma Ltd.
(founded in 2017) and Elpiscience Biopharmaceuticals, Inc. (founded in 2017).
He held the title of Chairman & Chief Executive Officer at both companies.
Dr. Ji is also the founder of PharmaLegacy Laboratories (Shanghai) Co., Ltd.
.
Dr. Ji's current job is as an Independent Director at Legend Biotech Corp.
(since 2020).
Dr. Ji's former jobs include being a Director at The BayHelix Group (from 2008 to 2013), Vice President-Business Development at Roche Holding AG (from 2013 to 2016), and a Partner at LAV Management Co., Ltd.
(from 2017 to 2020).
Dr. Ji's education includes an MBA from The University of Chicago, a doctorate from The University of Sheffield, and a doctorate from China Medical University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
LEGEND BIOTECH CORP.
0.01% | 31/12/2023 | 18 427 ( 0.01% ) | 368 632 $ | 31/05/2024 |
Posizioni attive di Xiao Hui Ji
Società | Posizione | Inizio |
---|---|---|
LEGEND BIOTECH CORPORATION | Direttore/Membro del Consiglio | 01/05/2020 |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Amministratore Delegato | 01/06/2017 |
Elpiscience Biopharmaceuticals, Inc.
Elpiscience Biopharmaceuticals, Inc. BiotechnologyHealth Technology Elpiscience Biopharmaceuticals, Inc. is an investment holding company, which engages in the research and development of immuno-oncology therapies. It focuses on the development of clinical-stage drug candidates namely, ES102, ES014, ES104, and ES009. The company was founded by Xiao Hui Ji and Hong Tao Lu in June 2017 and is headquartered in Shanghai, China. | Amministratore Delegato | 01/06/2017 |
Precedenti posizioni note di Xiao Hui Ji
Società | Posizione | Fine |
---|---|---|
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Corporate Officer/Principal | 01/05/2020 |
ROCHE HOLDING AG | Corporate Officer/Principal | 01/12/2016 |
The BayHelix Group | Direttore/Membro del Consiglio | 01/01/2013 |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Amministratore Delegato | 01/01/2012 |
Formazione di Xiao Hui Ji
China Medical University | Doctorate Degree |
The University of Sheffield | Doctorate Degree |
The University of Chicago | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
LEGEND BIOTECH CORPORATION | Health Technology |
ROCHE HOLDING AG | Health Technology |
Aziende private | 5 |
---|---|
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Health Technology |
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Finance |
The BayHelix Group | |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Commercial Services |
Elpiscience Biopharmaceuticals, Inc.
Elpiscience Biopharmaceuticals, Inc. BiotechnologyHealth Technology Elpiscience Biopharmaceuticals, Inc. is an investment holding company, which engages in the research and development of immuno-oncology therapies. It focuses on the development of clinical-stage drug candidates namely, ES102, ES014, ES104, and ES009. The company was founded by Xiao Hui Ji and Hong Tao Lu in June 2017 and is headquartered in Shanghai, China. | Health Technology |
- Borsa valori
- Insiders
- Xiao Hui Ji